📊 COSM Key Takeaways
Is Cosmos Health Inc. (COSM) a Good Investment?
Cosmos Health is operationally unprofitable with negative cash flow, burning through minimal cash reserves at an unsustainable rate. The company's critically weak 7.7% gross margin in the low-margin wholesale drug distribution business cannot support operating expenses, leaving only 5-6 months of cash runway before potential liquidity crisis.
Cosmos Health's fundamentals remain weak: revenue growth is minimal, gross margin is thin at 12.8%, and the business is still deeply unprofitable at both operating and net levels. Financial flexibility looks constrained by sub-1.0 current liquidity, very low cash, negative operating cash flow, and negative interest coverage, which together raise concern about near-term funding needs. While losses and EPS improved year over year, the improvement does not yet offset the company's poor growth quality and fragile balance-sheet liquidity.
Cosmos Health Inc. Key Strengths (COSM)
- Revenue growing 19.9% year-over-year demonstrates persistent market demand
- Reasonable debt/equity ratio of 0.17x avoids extreme leverage risk
- EPS improving 46.2% YoY from prior year loss indicates partial cost control progress
- Revenue is still growing modestly year over year, indicating the business has not stalled completely
- Leverage is not extreme, with debt-to-equity of 0.23x and long-term debt at a manageable absolute level
- Book equity remains positive at $23.13M, providing some balance-sheet cushion
COSM Stock Risks: Cosmos Health Inc. Investment Risks
- Catastrophic cash depletion: $514.7K cash against $1.1M quarterly operating cash burn provides critical liquidity crisis within months
- Negative operating cash flow proves core business is value-destructive; company cannot self-fund operations
- Gross margin of 7.7% structurally insufficient to cover operating expenses in a low-margin wholesale distribution business
- Persistent operating and net losses show the core business model is not yet generating sustainable profitability
- Liquidity is tight, with a 0.99x current ratio, 0.84x quick ratio, and less than $1M of cash
- Negative operating cash flow and free cash flow increase the risk of external financing or dilution if losses continue
Key Metrics to Watch
- Cash balance trajectory and monthly burn rate - determines solvency timeline
- Gross margin expansion - critical to achieving operational breakeven and sustainability
- Operating cash flow inflection - must achieve positive OCF to prove business model viability
- Operating cash flow and cash balance
- Gross margin and operating margin
Cosmos Health Inc. (COSM) Financial Metrics & Key Ratios
💡 AI Analyst Insight
Cosmos Health Inc. presents a mixed fundamental picture. Review the detailed metrics above to form your own investment thesis.
COSM Profit Margin, ROE & Profitability Analysis
COSM vs Market Sector: How Cosmos Health Inc. Compares
How Cosmos Health Inc. compares to Market sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Cosmos Health Inc. Stock Overvalued? COSM Valuation Analysis 2026
Based on fundamental analysis, Cosmos Health Inc. has mixed fundamental signals relative to the Market sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Cosmos Health Inc. Balance Sheet: COSM Debt, Cash & Liquidity
COSM Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: Cosmos Health Inc.'s revenue has grown significantly by 16% over the 5-year period, indicating strong business expansion. The most recent EPS of $-1.17 indicates the company is currently unprofitable.
COSM Revenue Growth, EPS Growth & YoY Performance
COSM Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $13.7M | -$818.1K | $-0.03 |
| Q3 2025 | $12.4M | -$5.4M | $-0.17 |
| Q2 2025 | $13.2M | -$2.6M | $-0.10 |
| Q1 2025 | $13.7M | -$818.1K | $-0.03 |
| Q3 2024 | $12.4M | -$459.9K | $-0.27 |
| Q2 2024 | $12.4M | -$459.9K | $-0.09 |
| Q1 2024 | $12.3M | -$459.9K | $-0.04 |
| Q3 2023 | $12.0M | $203.3K | $-0.27 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
Cosmos Health Inc. Dividends, Buybacks & Capital Allocation
COSM SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Cosmos Health Inc. (CIK: 0001474167)
📋 Recent SEC Filings
❓ Frequently Asked Questions about COSM
What is the AI rating for COSM?
Cosmos Health Inc. (COSM) has a Combined AI Grade of D from Claude (D) and ChatGPT (D) with 90% combined confidence, based on fundamental analysis of SEC EDGAR filings.
What are COSM's key strengths?
Claude: Revenue growing 19.9% year-over-year demonstrates persistent market demand. Reasonable debt/equity ratio of 0.17x avoids extreme leverage risk. ChatGPT: Revenue is still growing modestly year over year, indicating the business has not stalled completely. Leverage is not extreme, with debt-to-equity of 0.23x and long-term debt at a manageable absolute level.
What are the risks of investing in COSM?
Claude: Catastrophic cash depletion: $514.7K cash against $1.1M quarterly operating cash burn provides critical liquidity crisis within months. Negative operating cash flow proves core business is value-destructive; company cannot self-fund operations. ChatGPT: Persistent operating and net losses show the core business model is not yet generating sustainable profitability. Liquidity is tight, with a 0.99x current ratio, 0.84x quick ratio, and less than $1M of cash.
What is COSM's revenue and growth?
Cosmos Health Inc. reported revenue of $17.9M.
Does COSM pay dividends?
Cosmos Health Inc. does not currently pay dividends.
Where can I find COSM SEC filings?
Official SEC filings for Cosmos Health Inc. (CIK: 0001474167) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is COSM's EPS?
Cosmos Health Inc. has a diluted EPS of $-0.06.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined grade reflects both perspectives for balanced insights.
What is COSM's fundamental grade?
Based on our AI fundamental analysis in June 2026, Cosmos Health Inc. has a D grade with 90% confidence. Review the strengths and risks sections above for full context. This is not investment advice.
Is COSM stock overvalued or undervalued?
Valuation metrics for COSM: ROE of -14.1% (sector avg: 15%), net margin of -15.6% (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
What is COSM's AI grade for 2026?
Our dual AI analysis gives Cosmos Health Inc. a combined D grade for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is COSM's free cash flow?
Cosmos Health Inc.'s operating cash flow is $-1.1M, with capital expenditures of $11.4K. FCF margin is -6.0%.
How does COSM compare to other Market stocks?
Vs Default sector averages: Net margin -15.6% (avg: 12%), ROE -14.1% (avg: 15%), current ratio 1.08 (avg: 1.8).